Information Provided By: 
Fly News Breaks for April 29, 2015
IDXX
Apr 29, 2015 | 08:23 EDT
Canaccord said the sharp sell-off in IDEXX shares implies structural weakness, but the firm believes its fundamental story remains intact. The firm cited wins from competitive accounts, growth potential for Catalyst One, and sees the potential for competitive wins from Antech Diagnostics. Canaccord reiterated its Buy rating but lowered its price target to $160 from $175 on IDEXX shares.
News For IDXX From the Last 2 Days
There are no results for your query IDXX
